Plain-English translation of NCT07384442 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Parkinson's Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new treatment called targeted temporal interference stimulation (TIS) that uses gentle electrical stimulation to target specific areas deep in the brain called the cerebellar nuclei. Researchers believe this approach may help reduce tremor and improve walking ability in people with Parkinson's disease by calming overactive brain circuits. Some participants will receive the real stimulation, while others will receive a placebo (sham) stimulation so researchers can see how much benefit comes from the actual treatment.
Parkinson's disease causes progressive damage to brain cells that control movement, leading to tremors, stiffness, and walking problems that can significantly impact quality of life. Recent research suggests the cerebellum—a brain region involved in coordination and balance—plays an important role in these symptoms, so this new treatment targets that area to see if it can offer relief beyond current medicines.
If you qualify, you will be randomly assigned to receive either real brain stimulation or sham (fake) stimulation targeting the same brain region. During the study, you will visit the research center for sessions where the stimulation is delivered—a non-invasive procedure done through electrodes on your scalp. You will also complete walking tests, tremor assessments, and questionnaires to help researchers measure how well the treatment works. The study involves about 50 participants total, and your involvement would include several visits over the treatment period.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
China